Skip to content

Effectiveness of homoeopathic medicine in the treatment of menopause related complaints

"synopsis on Effectiveness of Homoeopathic medicine selected using Boenninghausens characteristics & repertory by Dr.C.M.Boger in the treatment of Menopausal syndrome- an open label prospective clinical study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043102
Enrollment
40
Registered
2022-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N959- Unspecified menopausal and perimenopausal disorder

Interventions

Intervention1: homoeopathic medicine after repertorization done using boenninghausens characteristics & repertory by Dr.C.M.Boger: Female patients those who are qualifying to inclusion criteria will b

Sponsors

National Institute of HomoeopathyKolkata
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female Patients of age group 40-60 with natural menopause. 2. Female patients who are able to read, write or understand Bengali or Hindi or English. 3. Female patients willing to take part in the study and ready to give written consent for the same 4. Female Patients who have amenorrhea since last 12 months on entering menopausal age. 5. Female Patients who are having minimum score 22 using Menopausal Rating Scale. 6. Female Patients of all religion and of different socioeconomic status. 7. Female patients with known but controlled systemic diseases.

Exclusion criteria

Exclusion criteria: 1. Female Patients who have undergone hysterectomy surgery. 2. Female patients using any medicine or supplement containing oestrogen and progesterone. 3. Female patients with uncontrolled systemic illness or any organ failure. 4. Female patients who are on substance abuse or dependence. 5. Female patients suffering from any life threatening/ psychiatric illness or immune compromised state. 6. Females who are unwilling to participate in study and not ready to give written consent for the same. 7. Female patients who are taking Homoeopathic medicine for any other illness.

Design outcomes

Primary

MeasureTime frame
Menopausal rating scaleTimepoint: At baseline & at the end of 3rd month

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDR Amitava Samanta

National Institute of Homoeopathy

samanta.amitava1@gmail.com9433485138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026